Vertex Pharmaceuticals Inc
VRTX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Revenue | $1.41B | $870.11M | $651.63M | $458.71M |
| Net Income | $583.23M | $1.55B | $100.68M | $32.95M |
| EPS Diluted | $2.23 |
Vertex Pharmaceuticals Inc · CIK 875320 · Engraved from SEC EDGAR
| $5.97 |
| $0.39 |
| $0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.